
SmPC Translation: How Errors Lead to Drug Recall Risks
Learn how pharmaceutical translation errors in SmPCs and patient leaflets lead to drug recalls, regulatory sanctions, and patient safety risks. Updated with 2025-2026 EU pharma legislation reform, EMA ePI roadmap, and AI translation developments.